3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Thyroid Neoplasms
2
Myelodysplastic Syndromes
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Tobacco Use Disorder
1
Thyroid Nodule
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mouth Neoplasms
1
Monoclonal Gammopathy of Undetermined Significance
1
Lichen Planus
1
Leukokeratosis, Hereditary Mucosal
1
Leukemia, Myeloid, Acute
1
Fanconi Anemia
1
Erythroplasia
1
COVID-19
1
Anemia
1
Interventions
Cyclophosphamide
57
fludarabine phosphate
48
Tacrolimus
39
Peripheral Blood Stem Cell Transplantation
37
Busulfan
36
Mycophenolic Acid
34
Whole-Body Irradiation
31
Antilymphocyte Serum
28
Methotrexate
26
Cyclosporine
25
fludarabine
23
Melphalan
18
Filgrastim
15
Radiotherapy
14
thymoglobulin
12
ruxolitinib
12
Methylprednisolone
12
Cord Blood Stem Cell Transplantation
12
Stem Cell Transplantation
11
Sirolimus
11
Psychiatric Rehabilitation
9
Flow Cytometry
9
Etoposide
9
Specimen Handling
7
Granulocyte Colony-Stimulating Factor
7
merphos
6
Therapeutics
6
Decitabine
6
Cyclosporins
6
Azacitidine
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Primary Myelofibrosis
×
Molecular Diagnostic Techniques
×
Clear all
NCT02435550
2019-12-20
iCare for Cancer Patients
University of Florida
Phase NA
Terminated
136 enrolled